194 related articles for article (PubMed ID: 26759329)
41. Effectiveness of single-session ultrasound-guided percutaneous ethanol sclerotherapy in simple breast cysts.
Özgen A
Diagn Interv Radiol; 2016; 22(3):220-3. PubMed ID: 27087190
[TBL] [Abstract][Full Text] [Related]
42. Percutaneous treatment of simple renal cysts with sclerotherapy and extended drainage.
Agostini S; Dedola GL; Gabbrielli S; Scelzi S; Dattolo E; Muzzillo F; Masi A
Radiol Med; 2004; 108(5-6):522-9. PubMed ID: 15722998
[TBL] [Abstract][Full Text] [Related]
43. Aspiration sclerotherapy combined with pasireotide to improve reduction of large symptomatic hepatic cysts (SCLEROCYST): study protocol for a randomized controlled trial.
Wijnands TF; Gevers TJ; Kool LJ; Drenth JP
Trials; 2015 Mar; 16():82. PubMed ID: 25873132
[TBL] [Abstract][Full Text] [Related]
44. [Giant hepatic cyst in a patient with ADPKD].
Pisani A; Riccio E; Imbriaco M; Capuano I; Rossano R; Santangelo M
G Ital Nefrol; 2012; 29(6):716-9. PubMed ID: 23229669
[TBL] [Abstract][Full Text] [Related]
45. Percutaneous transcatheter hepatic artery embolization for liver cysts in autosomal dominant polycystic kidney disease.
Takei R; Ubara Y; Hoshino J; Higa Y; Suwabe T; Sogawa Y; Nomura K; Nakanishi S; Sawa N; Katori H; Takemoto F; Hara S; Takaichi K
Am J Kidney Dis; 2007 Jun; 49(6):744-52. PubMed ID: 17533017
[TBL] [Abstract][Full Text] [Related]
46. Multidisciplinary management of chronic refractory pain in autosomal dominant polycystic kidney disease.
van Luijk F; Gansevoort RT; Blokzijl H; Groen GJ; de Haas RJ; Leliveld AM; Meijer E; Perdok JM; Stellema R; Wolff AP; Casteleijn NF
Nephrol Dial Transplant; 2023 Feb; 38(3):618-629. PubMed ID: 35512573
[TBL] [Abstract][Full Text] [Related]
47. Pasireotide does not improve efficacy of aspiration sclerotherapy in patients with large hepatic cysts, a randomized controlled trial.
Wijnands TFM; Gevers TJG; Lantinga MA; Te Morsche RH; Schultze Kool LJ; Drenth JPH
Eur Radiol; 2018 Jun; 28(6):2682-2689. PubMed ID: 29318424
[TBL] [Abstract][Full Text] [Related]
48. Polycystic kidney disease with renal calculi treated by percutaneous nephrolithotomy: a report of 11 cases.
Zhang J; Zhang J; Xing N
Urol Int; 2014; 92(4):427-32. PubMed ID: 24481047
[TBL] [Abstract][Full Text] [Related]
49. Cyst ablation using a mixture of N-butyl cyanoacrylate and iodized oil in patients with autosomal dominant polycystic kidney disease: the long-term results.
Kim SH; Kim SH; Cho JY
Korean J Radiol; 2009; 10(4):377-83. PubMed ID: 19568466
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of efficacy, safety, pain perception and health-related quality of life of percutaneous ethanol injection as first-line treatment in symptomatic thyroid cysts.
Reverter JL; Alonso N; Avila M; Lucas A; Mauricio D; Puig-Domingo M
BMC Endocr Disord; 2015 Nov; 15():73. PubMed ID: 26610707
[TBL] [Abstract][Full Text] [Related]
51. Ethanol sclerotherapy of ovarian endometrioma: a safe and effective minimal invasive procedure. Preliminary results.
García-Tejedor A; Castellarnau M; Ponce J; Fernández ME; Burdio F
Eur J Obstet Gynecol Reprod Biol; 2015 Apr; 187():25-9. PubMed ID: 25739052
[TBL] [Abstract][Full Text] [Related]
52. Foam Sclerotherapy for Cyst Volume Reduction in Autosomal Dominant Polycystic Kidney Disease: A Prospective Cohort Study.
Iliuta IA; Shi B; Pourafkari M; Akbari P; Bruni G; Hsiao R; Stella SF; Khalili K; Shlomovitz E; Pei Y
Kidney Med; 2019; 1(6):366-375. PubMed ID: 32734217
[TBL] [Abstract][Full Text] [Related]
53. Laparoscopic cyst decortication using the harmonic scalpel for symptomatic autosomal dominant polycystic kidney disease.
McNally ML; Erturk E; Oleyourryk G; Schoeniger L
J Endourol; 2001 Aug; 15(6):597-9. PubMed ID: 11552783
[TBL] [Abstract][Full Text] [Related]
54. Symptomatic simple renal cyst: comparison of continuous negative-pressure catheter drainage and single-session alcohol sclerotherapy.
Zerem E; Imamovíc G; Omerovíc S
AJR Am J Roentgenol; 2008 May; 190(5):1193-7. PubMed ID: 18430831
[TBL] [Abstract][Full Text] [Related]
55. Alcohol sclerosis for polycystic liver disease and obstructive jaundice: use of a nasobiliary catheter.
Dumot JA; Fields MS; Meyer RA; Shay SS; Conwell DL; Brzezinski A
Am J Gastroenterol; 1994 Sep; 89(9):1555-7. PubMed ID: 8079938
[TBL] [Abstract][Full Text] [Related]
56. Imaging features of tuberous sclerosis complex with autosomal-dominant polycystic kidney disease: a contiguous gene syndrome.
Back SJ; Andronikou S; Kilborn T; Kaplan BS; Darge K
Pediatr Radiol; 2015 Mar; 45(3):386-95. PubMed ID: 25355409
[TBL] [Abstract][Full Text] [Related]
57. Clinical experience of single-session percutaneous aspiration and OK-432 sclerotherapy for treatment of simple renal cysts: 1-year follow-up.
Choi YD; Ham WS; Kim WT; Cho KS; Lee JH; Cho SY; Seo JW; Jin OH
J Endourol; 2009 Jun; 23(6):1001-6. PubMed ID: 19459755
[TBL] [Abstract][Full Text] [Related]
58. Percutaneous treatment of pyocystis in patients with autosomal dominant polycystic kidney disease.
Akinci D; Turkbey B; Yilmaz R; Akpinar E; Ozmen MN; Akhan O
Cardiovasc Intervent Radiol; 2008; 31(5):926-30. PubMed ID: 18196333
[TBL] [Abstract][Full Text] [Related]
59. Increased psychosocial risk, depression and reduced quality of life living with autosomal dominant polycystic kidney disease.
Simms RJ; Thong KM; Dworschak GC; Ong AC
Nephrol Dial Transplant; 2016 Jul; 31(7):1130-40. PubMed ID: 26268712
[TBL] [Abstract][Full Text] [Related]
60. Apelin and copeptin: two opposite biomarkers associated with kidney function decline and cyst growth in autosomal dominant polycystic kidney disease.
Lacquaniti A; Chirico V; Lupica R; Buemi A; Loddo S; Caccamo C; Salis P; Bertani T; Buemi M
Peptides; 2013 Nov; 49():1-8. PubMed ID: 23973863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
